Natural Language Processing
Functional seizures
Algorithm to detect functional seizures, also known as:
Psychogenic nonepileptic seizures
Nonepileptic attack disorder
Pseudoseizures
Hystero-epilepsy
Conversion disorder with seizures
Dissociative Seizures
Owner Phenotyping Groups:
View Phenotyping Groups:
Final
Hearing Loss
Phenotype Description: individuals with sensorineural hearing loss (SNHL)
Below are algorithms used to identify individuals with SNHL at BioVU. If you have questions regarding any of the information presented on this page, you may contact either:
Wei-Qi Wei at wei-qi.wei@vanderbilt.edu or Joshua Denny at josh.denny@vanderbilt.edu
Owner Phenotyping Groups:
View Phenotyping Groups:
Final
High-Density Lipoproteins (HDL)
Algorithm to identify patients with low levels of high-density lipoproteins (HDL).
FLOWCHART of HDL Phenotyping Process
Owner Phenotyping Groups:
View Phenotyping Groups:
Final
Hypothyroidism
Project Outline: Selection of all Caucasian patients with hypothyroidism without a secondary cause of surgical removal or radiological ablation. The search is designed to eliminate subclinical hypothyroidism (by requiring that patients be on a replacement medication), medication-induced hypothyroidism (e.g., PTU, lithium, or history of amiodarone), and transient causes (e.g., pregnancy or subacute thyroiditis).
Owner Phenotyping Groups:
View Phenotyping Groups:
Final
Identification of Fibromyalgia Patients in a Rheumatoid Arthritis Cohort
Fibromyalgia has been estimated to affect 12-17% of rheumatoid arthritis patients (1, 2).
This algorithm was created to identify fibromyalgia patients in a population of rheumatoid arthritis patients. The gold standard used for diagnosis of fibromyalgia was that the treating rheumatologist made a clinical diagnosis of fibromyalgia. Rheumatoid arthritis patients were identified by using a previously validated algorithm (3).
Algorithm included the following conditions:
Owner Phenotyping Groups:
Final
Liver cancer staging project
Hepatocellular carcinoma (HCC), the primary form of liver cancer, is one of the leading cancer-related causes of death worldwide. There are many complex treatment strategies; the populations are heterogeneous, with different genetic, lifestyle, and comorbity differences.
Here we describe the algorithm used to identify HCC liver cancer stages for AJCC, BCLC, and CLIP liver cancer staging systems.
Algorithm:
Step 1) Patient files and laboratories
Final
Multiple Sclerosis - Demonstration Project
Multiple Sclerosis (MS) phenotype algorithm for the DNA Databank demonstration project.
Owner Phenotyping Groups:
View Phenotyping Groups:
Final
Non-alcoholic fatty liver disease (NALFD) & Alcoholic Fatty Liver Disease (ALD)
Non-alcoholic fatty liver disease (NAFLD)
Owner Phenotyping Groups:
View Phenotyping Groups:
Final